Comprehensive Study on Mammography Industry

Mammography (also called mastography) uses low-energy X-rays (usually around 30 kVp) to examine the human breast for diagnosis and screening. The goal of mammography is the early detection of breast cancer, typically by detecting characteristic masses or microcalcifications.

Get Sample PDF

Some of the key players of Mammography Industry:

Analogic Corporation, Carestream Health, Fujifilm Holdings Corporation, General Electric Company, Hologic, Inc., Konica Minolta, Inc., Koninklijke Philips N.V., PLANMED OY, Siemens AG, Toshiba Medical Systems Corporation

As with all X-rays, mammograms use doses of ionizing radiation to create images. These images are then analyzed for abnormal findings. It is common to use lower energy x-rays, typically Mo (K-shell x-ray energies of 17.5 and 19.6 keV) and Rh (20.2 and 22.7 keV) than those used for radiography of bones be used. Ultrasound, ductography, positron emission mammography (PEM) and magnetic resonance imaging (MRI) are additions to mammography.

Ultrasound is typically used to further evaluate masses found on mammograms or palpable masses not seen in mammograms. Some facilities still use ductograms to assess bloody nipple discharge when the mammogram is not diagnostic. MRI can be useful for further evaluating questionable findings as well as screening preoperative evaluation in patients with known breast cancer to identify additional lesions that could change the surgical approach, such as: B. from a breast-conserving lumpectomy to a mastectomy. Other methods studied include tomosynthesis.